Cure My Disease

Don't miss your cure!

 Log in / Sign up

Spinal implants pass 24-Month safety check in 77 patients

NCT ID NCT04670536

Completed Disease control Sponsor: Medicrea International Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 77 adults who received spinal implants (PASS LP, PASS DEGEN, or PASS TULIP PRIME) to treat degenerative spine conditions like disc degeneration or spinal deformity. The main goal was to see if the bones fused properly after 24 months. Researchers also tracked pain and quality of life changes. The study is already completed and supports the implants' safety and effectiveness for medium-term use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PASS LP, PASS DEGEN, and PASS TULIP PRIME spinal implants
What this could lead to
If successful, this could confirm that these implants are safe and effective for fusing spine bones in people with degenerative spine disease.
What could go wrong
This is a small, completed post-market study with no control group, so results may not apply to everyone. Fusion may fail or complications could occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL DEFORMITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spondylolisthesis spondylosis thoracic disk degenerative disorder vertebral column disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SPINAL DEFORMITY SPINAL DEGENERATION THORACOLUMBAR DISC DEGENERATION THORACOLUMBAR SPONDYLOLISTHESIS

Contacts and locations

Locations

  • CHRU Tours, Hôpital de Bretonneau

    Tours, 37044, France

  • Clinique des Cèdres

    Cornebarrieu, 31700, France

  • Clinique du Dos Bordeaux - Terrefort

    Bruges, 33520, France

  • Hôpital Pitié-Salpêtrière AP-HP

    Paris, Île-de-France Region, 75651, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.